The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest liquid biopsy market share.

The global liquid biopsy market is expected to grow from $5.17 billion in 2022 to $6.68 billion in 2023 at a compound annual growth rate (CAGR) of 29.3%. The global liquid biopsy market is expected to grow to $20.39 billion in 2027 at a CAGR of 32.2%.

Major Driver In The Liquid Biopsy Market ­– Rise In Government Funds For Refining Cancer Detection
For example, the National Cancer Institute (NCI), a government organisation based in the United States, increased its grant amounts to $678,000 in 2021 from $570,000 in 2020. Furthermore, the National Institute of Health (NIH), an American medical research organisation, was allotted $46.6 billion in 2022, and the National Cancer Institute (NCI), an American cancer research agency, was awarded $6.9 billion for furthering cancer research. As a result, government funds have a beneficial impact on the expansion of the liquid biopsy industry.

View More On The Liquid Biopsy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Key Liquid Biopsy Market Segments
1) By Product: Assays Kits, Instruments, Services
2) By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers
3) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics

Recent Liquid Biopsy Market Trend – Adopting New Market Dynamics And Focusing Primarily On New Product Launches
Companies are fast adapting to changing market dynamics and focusing primarily on new product introductions in order to meet the ever-increasing demand for liquid biopsy products and services, boost revenue, and gain a competitive advantage over their competitors. As an example, Personalis, Inc., a USA-based advanced cancer genomics firm, announced the release of NeXT Liquid Biopsy, a high-performance, exome-scale tumor-profiling instrument that takes blood samples from novel solid tumour cancer patients, in August 2020. When paired with Personalis’ premier immunoid NeXT tissue profiling technology, NeXT Liquid Biopsy, a more detailed immuno-genomics image of the tumour may now be followed over time using blood samples. These talents can help biopharmaceutical companies enhance their understanding of tumour biology, specifically resistance mechanisms, in order to develop next-generation cancer medicines. As a result, firms in the liquid biopsy market are investing in the development of new products.

Liquid Biopsy Market Prominent Players
Major players in the liquid biopsy market are QIAGEN N.V., Roche Diagnostics, Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific, Guardant Health, Menarini Silicon Biosystems, Biocept Inc., F. Hoffmann-La Roche AG, Janssen Diagnostics LLC., Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Cygnus Biosciences, Illumina Inc., Oxford Nanopore, and Quantum Biosystems.

Request A Sample Of The Global Liquid Biopsy Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp

The Liquid Biopsy Global Market Report 2023  provides a comprehensive overview on the liquid biopsy market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the liquid biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A liquid biopsy is a rapid and painless alternative to surgical biopsies that enables doctors to learn a lot about a tumour from a small blood sample. A liquid biopsy is a blood diagnostic procedure that detects the presence of malignant cells in the blood. It is used to identify cancer early on.

View More Related Reports –
Biopsy Devices Global Market Report 2023
Liquid Ring Vacuum Pumps Global Market Report 2023
Liquid Fertilizers Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model